RESUMO
No disponible
No disponible
Assuntos
Humanos , Geriatria/educação , Geriatria/ética , Espanha , Biografias como Assunto , Ensino/ética , Idoso/fisiologia , Cruz Vermelha , Geriatria , Geriatria/métodos , Espanha/etnologia , Ensino/métodos , Idoso/psicologia , Cruz Vermelha/organização & administraçãoRESUMO
No disponible
No disponible
Assuntos
Humanos , Masculino , Feminino , Idoso , Idoso de 80 Anos ou mais , Educação Continuada/ética , Educação Continuada/métodos , Geriatria/educação , Geriatria/ética , Envelhecimento/genética , Pessoal de Saúde/educação , Biografias como Assunto , Educação Continuada , Educação Continuada/normas , Geriatria , Geriatria/métodos , Envelhecimento/metabolismo , Pessoal de Saúde/psicologiaRESUMO
A comparative, randomized and cross clinical trial between nisoldipine and alpha-methyldopa in 50 aged patients with isolated systolic hypertension during 12 weeks. The therapeutic aim (SAP less than or equal to 160 mmHg) was reached after the first period in the 60% of the patients treated with nisoldipine and the 63% of those who took alpha-methyldopa (ns), and after the second period: 77% in nisoldipine group and 82% for alpha-methyldopa (ns). Adverse effects were experienced in the 21.7% of the patients treated with nisoldipine and in the 60.8% of the patients who received alpha-methyldopa (p less than 0.001. Nisoldipine had a lower effect that alpha-methyldopa over the diastolic arterial pressure. It was not any change in the biochemical parameters related to both antihypertensive drugs.
Assuntos
Hipertensão/tratamento farmacológico , Metildopa/uso terapêutico , Nisoldipino/uso terapêutico , Fatores Etários , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Masculino , Metildopa/administração & dosagem , Metildopa/efeitos adversos , Nisoldipino/administração & dosagem , Nisoldipino/efeitos adversos , Sístole , Fatores de TempoAssuntos
Geriatria , Serviços de Saúde para Idosos , Idoso , Envelhecimento , Geriatria/educação , Geriatria/tendências , Humanos , PesquisaRESUMO
The bad use and overload of hospital emergency rooms (HER) constitute a problem in present health assistance. Old patients are often blamed of a misuse of this health care assistance. The results of studies analyzing the behaviour of older patients at HER show that this group of patients utilize this service more adequately than younger adults, since they go to the emergency room with more justifiable reason, with more severe diseases and require more hospital admissions. On the other hand, older patients consume more time in the HER than what would proportionally correspond to this group in the community. It is interesting to keep these data in mind when planning health assistance.
Assuntos
Serviço Hospitalar de Emergência/estatística & dados numéricos , Serviços de Saúde para Idosos/estatística & dados numéricos , Idoso , Mau Uso de Serviços de Saúde/estatística & dados numéricos , Necessidades e Demandas de Serviços de Saúde/estatística & dados numéricos , Humanos , EspanhaRESUMO
In this study we analyze the evolution of 85 patients included in a geriatric home care (GHC) program after 18 months. Mean age was 82 years, with a mean 4 diagnosis per patient and treatment with a mean of 3 drugs per patient. Of these patients 53% presented physical and 36% mental severe deterioration. After 18 months, 39% of the patients had died and 25% continued in the program. Readmissions at the geriatric ward was only 16% in the 18 months of follow-up. The most deteriorated patients required a greater nursery attention and less pharmacological treatment. Male patients presented more pluripathology, required more nurse techniques and died more frequently than females, who were more frequently discharged. These data contribute to the better knowledge of GHC, a care level which should be considered when planning health assistance of the elderly.
Assuntos
Serviços de Saúde para Idosos , Serviços de Assistência Domiciliar , Idoso , Idoso de 80 Anos ou mais , Feminino , Seguimentos , Necessidades e Demandas de Serviços de Saúde/estatística & dados numéricos , Serviços de Saúde para Idosos/estatística & dados numéricos , Serviços de Assistência Domiciliar/estatística & dados numéricos , Humanos , Estudos Longitudinais , Masculino , Mortalidade , Readmissão do Paciente/estatística & dados numéricos , EspanhaRESUMO
One hundred and eleven low-moderate hypertense elderly patients treated with nitrenpidine or chlortalidone were studied during 4 months either on monotherapy or in combination according to the therapeutic response observed. The therapeutic goal (diastolic arterial pressure less than 95 mmHg) was obtained in 92.4% of patients on nintrenpidine and in 49.1% on chlortidone, both on monotherapy (2 months) (p less than 0.001). At the end of the study 96.3% of patients reaches the therapeutic goal. Secondary effects were observed in 8.3% of patients on nitrenpidine and 6.1% on chlortalidone and in 11.1% of patients on combined treatment. No abnormalities were observed in blood biochemistry studied nor was there evidence of a significant influence of any of the two drugs on the patients quality of life which was evaluated through a specific questionnaire specially designed.
